Initial dosage regimens of vancomycin for Chinese adult patients based on population pharmacokinetic analysis

被引:27
|
作者
Deng, Chenhui [1 ,2 ]
Liu, Taotao [3 ]
Zhou, Tianyan [1 ,2 ]
Lu, Hua [3 ]
Cheng, Daohai [3 ]
Zhong, Xiaobing [3 ]
Lu, Wei [1 ,2 ]
机构
[1] Peking Univ, State Key Lab Nat & Biomimet Drugs, Beijing 100191, Peoples R China
[2] Peking Univ, Sch Pharmaceut Sci, Beijing 100191, Peoples R China
[3] Guangxi Med Univ, Affiliated Hosp 1, Guangxi, Peoples R China
关键词
vancomycin; Chinese adult patients; population pharmacokinetics; NONMEM; steady-state trough concentrations; RESISTANT STAPHYLOCOCCUS-AUREUS; NEPHROTOXICITY; INFECTIONS; OUTCOMES;
D O I
10.5414/CP201842
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective: To build a population pharmacokinetic model for Chinese adult patients and develop initial dosage regimens for patients with different degrees of renal function to achieve target steady-state trough concentrations in the range of 10 - 15 and 15 - 20 mg/l. Method: Data on serum vancomycin concentration was collected from a retrospective study including 72 Chinese adult patients. NON-MEM was used to build the population pharmacokinetic model, and a one-compartment model was chosen to describe the vancomycin concentration-time profile. Internal evaluation by bootstrap and visual predictive check (VPC) was performed to evaluate the robustness and prediction of the final model. Monte Carlo simulations were conducted to develop initial dosage regimens to achieve target trough concentrations. Results: A one-compartment model was built with creatinine clearance (CLcr) as the key covariate influencing drug clearance. The estimated drug clearance for patients with normal renal function (CLcr >= 80 ml/min) was 4.90 1/h, and 0.0654 x CLcr if CLcr was < 80 ml/min. The apparent volume of the central compartment was 47.76 1 and no covariate was found to affect it. The results of bootstrap analysis were in agreement with the original parameters of the final model, and VPC of the final model demonstrated good predictability. Initial dosage regimens were developed based on the simulations of the population pharmacokinetic model. Conclusion: A one-compartment model fitted the retrospective data and CLcr had a significant effect on drug clearance. Initial dosage regimens for vancomycin were proposed to provide some help to individual therapy for Chinese adult patients with different renal functions.
引用
收藏
页码:407 / 415
页数:9
相关论文
共 50 条
  • [1] A population pharmacokinetic model for individualised dosage regimens of vancomycin in Chinese neonates and young infants
    Song, Lin
    He, Cui-Yao
    Yin, Nan-Ge
    Liu, Fang
    Jia, Yun-Tao
    Liu, Yao
    ONCOTARGET, 2017, 8 (62) : 105211 - 105221
  • [2] Population pharmacokinetics of vancomycin in adult Chinese patients with post-craniotomy meningitis and its application in individualised dosage regimens
    Wei-wei Lin
    Wei Wu
    Zheng Jiao
    Rong-fang Lin
    Chang-zhen Jiang
    Pin-fang Huang
    Yi-wei Liu
    Chang-lian Wang
    European Journal of Clinical Pharmacology, 2016, 72 : 29 - 37
  • [3] Population pharmacokinetics of vancomycin in adult Chinese patients with post-craniotomy meningitis and its application in individualised dosage regimens
    Lin, Wei-wei
    Wu, Wei
    Jiao, Zheng
    Lin, Rong-fang
    Jiang, Chang-zhen
    Huang, Pin-fang
    Liu, Yi-wei
    Wang, Chang-lian
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 72 (01) : 29 - 37
  • [4] Population pharmacokinetic analysis of vancomycin in neonates. A new proposal of initial dosage guideline
    Marques-Minana, Maria-Remedios
    Saadeddin, Anas
    Peris, Jose-Esteban
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 70 (05) : 713 - 720
  • [5] Predictive performance of reported population pharmacokinetic models of vancomycin in Chinese adult patients
    Deng, C.
    Liu, T.
    Wu, K.
    Wang, S.
    Li, L.
    Lu, H.
    Zhou, T.
    Cheng, D.
    Zhong, X.
    Lu, W.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2013, 38 (06) : 480 - 489
  • [6] Evaluation of predictability for vancomycin dosage regimens by the Bayesian method with Japanese population pharmacokinetic parameters
    Teramachi, H
    Hatakeyama, H
    Matsushita, R
    Imai, Y
    Miyamoto, K
    Tsuji, A
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2002, 25 (10) : 1333 - 1338
  • [7] Dosage Optimization Based on Population Pharmacokinetic Analysis of Tacrolimus in Chinese Patients with Nephrotic Syndrome
    Lu, Tong
    Zhu, Xu
    Xu, Shansen
    Zhao, Mingming
    Huang, Xueshi
    Wang, Zhanyou
    Zhao, Limei
    PHARMACEUTICAL RESEARCH, 2019, 36 (03)
  • [8] Dosage Optimization Based on Population Pharmacokinetic Analysis of Tacrolimus in Chinese Patients with Nephrotic Syndrome
    Tong Lu
    Xu Zhu
    Shansen Xu
    Mingming Zhao
    Xueshi Huang
    Zhanyou Wang
    Limei Zhao
    Pharmaceutical Research, 2019, 36
  • [9] Influences of renal function descriptors on population pharmacokinetic modeling of vancomycin in Chinese adult patients
    Xi-wei Ji
    Shuang-min Ji
    Xiao-rong He
    Xiao Zhu
    Rong Chen
    Wei Lu
    Acta Pharmacologica Sinica, 2018, 39 : 286 - 293
  • [10] Population Pharmacokinetics of Vancomycin in Chinese ICU Neonates: Initial Dosage Recommendations
    Li, Zhi-ling
    Liu, Yi-xi
    Jiao, Zheng
    Qiu, Gang
    Huang, Jian-quan
    Xiao, Yu-bo
    Wu, Shu-jin
    Wang, Chen-yu
    Hu, Wen-juan
    Sun, Hua-jun
    FRONTIERS IN PHARMACOLOGY, 2018, 9